Literature DB >> 23032620

Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy.

Sabine Stegmaier, Stefan S Bielack, Ivo Leuschner, Thomas Klingebiel, Ewa Koscielniak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23032620     DOI： 10.1200/JCO.2012.43.5628

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?

Authors:  Tobias M Dantonello; Christian Vokuhl; Monika Scheer; Monika Sparber-Sauer; Sabine Stegmaier; Guido Seitz; Heike Scheithauer; Jörg Faber; Iris Veit-Friedrich; Peter Kaatsch; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak
Journal:  Virchows Arch       Date:  2018-02-21       Impact factor: 4.064

2.  Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers.

Authors:  Bryan R Helm; Xiaohui Zhan; Pankita H Pandya; Mary E Murray; Karen E Pollok; Jamie L Renbarger; Michael J Ferguson; Zhi Han; Dong Ni; Jie Zhang; Kun Huang
Journal:  Genes (Basel)       Date:  2019-08-30       Impact factor: 4.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.